Kathleen Kimpton

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Drug Administration

Positron Emission Tomography

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ernest Moles, Christopher B Howard, Pie Huda, Mawar Karsa, Hannah McCalmont, Kathleen Kimpton, Alastair Duly, Yongjuan Chen, Yizhou Huang, Melinda L Tursky, David Ma, Sonia Bustamante, Russell Pickford, Patrick Connerty, Sofia A Omari, Christopher J Jolly, Swapna Joshi, Sylvie Shen, John E Pimanda, Alla Dolnikov, Laurence C Cheung, Rishi Sury Kotecha, Murray D Norris, Michelle Haber, Charles E de Bock, Klaartje Somers, Richard B Lock, Kristofer J Thurecht, Maria Kavallaris
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. Science translational medicine 15 (696) (2023)
Ernest Moles, Christopher B Howard, Pie Huda, Mawar Karsa, Hannah McCalmont, Kathleen Kimpton, Alastair Duly, Yongjuan Chen, Yizhou Huang, Melinda L Tursky, David Ma, Sonia Bustamante, Russell Pickford, Patrick Connerty, Sofia A Omari, Christopher J Jolly, Swapna Joshi, Sylvie Shen, John E Pimanda, Alla Dolnikov, Laurence C Cheung, Rishi Sury Kotecha, Murray D Norris, Michelle Haber, Charles E de Bock, Klaartje Somers, Richard B Lock, Kristofer J Thurecht, Maria Kavallaris
Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia. Science translational medicine 15 (696) (2023)